|
|
| Research Activity |
- Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy after Drug-Eluting Stent Implantation (STAMP-DES trial)
- Evaluation of Effectiveness and Safety of Resolute Onyx™in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Acute Myocardial Infarction; A Multicenter, Prospective Observational Study
- Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Evaluation of Effectiveness and Safety of Ultimaster® stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Ten-Year Outcomes of Stents versus Coronary- Artery Bypass Grafting for Left Main Coronary Artery Disease;
- Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
- Implantable Cardioverter Defibrillator versus Optimal Medical Therapy In Patients with Variant Angina Manifesting as Aborted Sudden Cardiac Death (VARIANT-ICD trial)
- Quantitative Coronary Angiography versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation: GUIDE-BVS trial
- Efficacy of the CYPHER SelectTM Sirolimus-Eluting Coronary Stent Implantation for Coronary Artery Stenosis
- Randomized Comparison Study of CypherTM Stent Versus Brachytherpy for Treatment of Diffuse In-Stent Restenosis
- The Effect of Sirolimus-Eluting Stent for Very Long Coronary Lesions
- The Effect of Paclitaxel-Eluting Stent for Very Long Coronary Lesions
- Randomized Comparison of Triple Versus Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation; Will There Be a Synergy of DES and Cilostazol in Restenosis Reduction
- Effects of Rosiglitazone on Neointimal Hyperplasia After Coronary Stent Implantation in Patients with Diabetes Mellitus: A Serial Intravascular Ultrasound Study
- Comparison of Co-Cr alloy ArthosPico Stent with Sirolimus-Eluting Stent for Simple De Novo Coronary Lesions
- Efficacy of Sirolimus-Eluting Stent Implantation for Ostial Left Anterior Descending Artery Stenosis
- Comparison of Early and Mid-term Outcomes After Sirolimus-Eluting Stent implantation Versus Coronary Artery Bypass Grafting in Patients with Multivessel Coronary Artery Disease
- Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent: Cypher Versus Taxus : LONG-DES
- Identification of Patients at Low Risk of 6-Month Instent Restenosis of Bare Metal Stenting In the Real World
- Glycosylated Hemoglobin Level as a Predictor of Restenosis After Drug-Eluting Stent Implantation in Diabetes Mellitus Patients
- Tissue Plasminogen Activator on Admission is an Important Predictor for 30-day Mortality in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty
- Serial Intravascular Ultrasound Findings in Patients with Ruptured
- Coronary Plaques: Evidence of Both Plaque Stabilization and Lesion Progression
- Evaluation of Neo-endothelization at the Stent Over Lapping Segment After Kissing Stenting with Sirolimis-Eluting Stent
- Effects of Atorvastatin Versus Rosuvastatin Rherapy on Coronary Atherosclerotic Plaque: A Prospective Randomized Comparison Trial With Intravascular Ultrasound
- Validation of New Drug-Eluting Stent in a Porcine Coronary Artery Model of Restenosis
- Multicenter Study for Evaluating the Procedural Efficacy and Initial Safety of the TAXUS LiberteTM Paclitaxel-Eluting Stent in Coronary Lesions
- Valsartan for Suppression of Plaque Volume and Restenosis After Paclitaxel-Eluting Stent
- EuroSCORE as a Predictor of Death and Myocardial Infarction After Unprotected Left Main Coronary Stenting
- Repeated Sirolimus-Eluting Stent Implantation for the Treatment of Drug-Eluting Stent Restenosis: Comparison with Conventional Therapies
- Tritace PEP Study in Metabolic Syndrome
- Comparison of the Efficacy of Zotarolimus(ABT 578)-Eluting Stent Versus Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Coronary Lesions: The Prospective, Randomized, and Multi-center Trial
- Effects of Triple Antiplatelet Therapy on Platelet Function in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Stenting
- To Evaluate the ‘Real World’ Clinical Performance of the Medtronic EndeavorTM ABT-578 Eluting Coronary Stent System : A Prospective, Multicenter Registry(E-Five Registry)
- Premier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PhaseIII : Multicenter Trial: PRE-COMBAT Trial
- A Multicenter, Randomized, Double-Blind, Parallel Arm, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients with Metabolic Syndrome and Hpercholesterolemia at High Risk for Coronary Heart Disease
- Impact of Cilostazol on Neointimal Hyperplasia After ABT578-Eluting Stent Implantation in Patients with Long Coronary Lesions: Prospective, Double Blind, Randomized, and Multicenter trial
- Focal Type In-Stent Restenosis After Drug-Eluting Stent Implantation Treated by Cutting Balloon Angioplasty Versus Sirolimus-Eluting Stent
- Revascularization Treatment for Unprotected Left Main Coronary Artery Stenosis in Korea: Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Surgery “Left Main Registry in Korea”
- Evaluation of the Long-Term Safety After Zotarolimus-Eluting Stent, Sirolimus-Eluting Stent, or PacliTaxel-Eluting Stent Implantation for Coronary Lesions-Late Coronary Arterial Thrombotic Events: The ZEST-LATE trial
- Comparison Between Drug-Eluting Stents for the Treatment of the Diffuse Type In-Stent Restenosis After Drug-Eluting Stents Implantation: Sirolimus-Eluting vs. Paclitaxel-Eluting Stents (DES-ISR Trial)
- The e-SELECT Registry A MultiCenter Post Market Surveillance
- Preventive Strategies of REnal Insufficiency in Patients with Diabetes Undergoing InterVENTion or Arteriography: PREVENT Trial
- Correlation of Clopidogrel Therapy Discontinuation in REAL-world Patients Treated with Drug-Eluting Stent Implantation and Late Coronary Arterial Thrombotic Events: REAL-LATE Trial
- Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial Prospective, Multicenter, Randomized, Twoarm, Open-label Trial
- Optimal Stenting Strategy for True Bifurcation Lesion
- Choice of Optimal StRategy fOr Bifurcation LeSions with Normal Side Branch
- Comparison of the Efficacy and Safety of PaclItaxel-Eluting CoroflexTM Please Stent Versus Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
- Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-III: Sirolimus vs.Everlolimus-Eluting Stent
- The BEST TRIAL Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease: Phase IV: Multicenter trial
- Randomized Comparison of Everolimus- Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery DisEase in Patients with DIABETES Mellitus (ESSENCE-DIABETES TRIAL)
- A Randomized, Double-Blind, Single Center, Study of Effect of High-Dose(40mg) and Low-Dose(10mg) Statin for Coronary Plaque Modification
- Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the Asian Population
- Prospective Evaluation of Outcomes of Everolimus-Eluting Stent (XIENCE V) Implantation for Unprotected Left Main Coronary Artery Stenosis: Multicenter trial
- Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-III: Sirolimus vs. Zotarolimus-Eluting Stent
- Randomized Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients with DIABETES Mellitus
- Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients with Chronic Total Occlusion
- Effectiveness of Clopidogrel Resinate(PRegrelr) in Patients Undergoing Percutaneous Coronary Intervention compared with Clopidogrel Bisulfate(Plavix)
- Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
- New Aortic Valve Replacement in Selected High-Risk Patients with Aortic Stenosis without Conventional Sternotomy
- Evaluation of Effectiveness and Safety of PROMUS Element™ in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
- Evaluation of Effectiveness and Safety of NOBORI stent in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
- Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
- Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-V: Biolimus A9-Eluting (NOBORI) vs. Everolimus-eluting (PROMUS-ELEMENT) Stent
- Comparison of Long-Term Angiographic Efficacy of Zotarolimus-Eluting Stent with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for Coronary Lesions
- A Global Multicenter, Prospective, Real World Observational Study for Left Main Disease Treatment
- Triple Antiplatelet Therapy Significantly Reduces Ischemic Events After Drug-Eluting Stent Implantation; Drug-Eluting Stenting Followed by Cilostazol Treatment REduces Adverse Serious Cardiac Events (DECREASE-PCI Study)
- Randomized Comparison of Dual Drug-Eluting Cilotax Stent and Everolimus- Eluting Stent Implantation for DE Novo Coronary Artery DisEase in Patients with DIABETES Mellitus
- A Randomized, Double-Blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERed Coronary Disease
- Effects of Fimasartan on Plaque Progression and Stability in a Rabbit Model of Atherosclerosis
- Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-VI: Everolimus-eluting vs. Zotarolimus-Eluting Stents
- Geometric Effect on Fractional Flow Reserve: Computational Flow Dynamics Study
- Evaluation of Effectiveness and Safety of XIENCE PRIME™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- A Multicenter, Prospective Observational Cohort Study Of Effectiveness and Safety of RESOLUTE INTEGRITY for Patients with Complex Clinical and Lesion Subsets
- Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients with High-Risk Patent Foramen Ovale : DEFENSE-PFO trial
- The Efficacy and Safety of Edwards SAPEN XT Implantation in High Surgical Risk Patients with Severe Aortic Stenosis: Prospective, Single Center Study
- The Efficacy and Safety of Core valve Implantation in High Surgical Risk Patients with Severe Aortic Stenosis: Prospective, Single Center Study
- Evaluation of Effectiveness and Safety of the GENOUS STENT in ST-Segment Elevation Myocardial Infarction
- Effects of Fimasartan on Plaque Progression and Stability in a Rabbit Model of Atherosclerosis
- PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy -3 using Promus Element Everolimus-Eluting Coronary Stent System in Patients with Left Main Coronary Artery Disease
- PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy -3 using Resolute Integrity Zotarolimus-Eluting Coronary Stent System in Patients with Left Main Coronary Artery Disease
- PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy -5 Orsiro™ Coronary Stent System in Patients with Left Main Coronary Artery Disease
- A Multicenter, Real World Observational Study to Validate the Effectiveness and Safety of FFR guided PCI (IRIS-FFR Registry)
- Evaluation of Effectiveness and Safety of Cilotax Stent in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
- Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis Asan Multivessel Registry - Prospective cohort, Retrospective cohort
- Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort
- Educational Contents & Exercise Program Development for Cardiac Rehabilitation Solutions and Verify Effectiveness
- Evaluation of Effectiveness and Safety of Premier™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
- Evaluation of Effectiveness and Safety of Orsiro™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
- Evaluation of Effectiveness and Safety of Desyne™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
- Evaluation of Effectiveness and Safety of XIENCE XPEDITION™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
- EARly Prevention of aTHeroma Progression(EARTH trial)
- A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients with Acute Coronary Syndromes Intended for Invasive Management: TICAKOREA Trial
- Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Implantation in the Asian Population (the Asian TAVR registry)
- Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-luting Stent Implantation for De Novo Coronary Artery DisEase in Patients with DIABETES Mellitus: 5-Year clinical outcomes of ESSENCE DIABETES trial
- The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis with Vulnerable Plaque Characteristics
|
|
|
 |
CardioVascular Research Foundation(CVRF)
2nd Floor, Asan Institute for Education & Research, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Copyright ⓒ 2002 CVRF, Seoul, Korea. All rights reserved.
|
  
|
|
